Popular weight-loss and diabetes medications linked to lower risk of some cancers, study finds
GLP-1 medications such as Ozempic and Wegovy may help lower the risk of certain cancers, a new study suggests.
Popular weight loss drugs may be linked to a rare form of blindness — and more
A new study finds some popular weight loss and diabetes drugs may lead to a condition that causes a form of blindness. The condition is known as non-arteritic anterior ischemic optic neuropathy (NAION), which is a type of eye stroke that causes sudden, painless vision loss in one eye.
Ozempic & Wegovy may be linked to eye condition, vision loss: Study
Former FDA Commissioner Dr. Scott Gottlieb joins 'Squawk Box' to discuss a new study showing people taking Ozempic and Wegovy may be at an increased risk of developing an eye condition that can cause irreversible vision loss.
GLP-1 Drugs Like Wegovy, Ozempic Potentially Linked to Blinding Disease
In an observational retrospective study, researchers found that patients with type 2 diabetes or obesity who were taking semaglutide were more likely to develop a rare blinding condition than those taking a non-GLP-1 drug.
Ozempic and Wegovy May Be Linked to Increased Risk of Rare Form of Blindness — but More Research Is Needed
Authors of a new study say additional research is needed to determine causality between semaglutide and a condition called NAION
Popular weight-loss jabs Ozempic and Wegovy linked to condition that can cause blindness (cloned)
Popular weight-loss jabs Ozempic and Wegovy linked to condition that can cause blindness (cloned) - There are no current treatments for NAION and vision often does not improve
Ozempic may be linked to condition that causes blindness
A new study shows that people taking semaglutide, the active ingredient in Ozempic and Wegovy, are more likely to develop an optic nerve issue that can lead to sudden vision loss that has no known treatment.
verywellhealth on MSN11h
7 Surgical Weight-Loss Procedures: Choosing the Type for You
Several types of weight loss surgery are commonly performed in the United States, including gastric bypass and gastric ...
Weight-loss jabs linked to seven-fold increase in rare sight-loss disease
Weight-loss injections have been linked to a more than seven-fold increase in a rare sight-loss disease, a new study by ...
Coshocton Tribune on MSN16h
Coshocton County and other governments see higher insurance costs due to weight loss drugs
COSHOCTON − Doctors prescribing drugs used to treat Type 2 diabetes for weight loss not related to the disease is ...
New weight loss drug may be better than Ozempic — here’s how
The promising results of a phase 2 trial of pemvidutide were shared this week at the American Diabetes Association’s annual ...
Healthline3d
Can a Low Protein Diet Really Help You Lose Weight?
Content creators on social media platforms like TikTok are claiming very low protein diets are better for weight loss and ...
Tuko on MSN4d
Heather Rae Young's weight loss after Hashimoto's disease diagnosis
Heather Rae Young's weight loss has captivated the attention of fans and followers worldwide. Find out more about her journey ...
Newsweek on MSN2d
Weight-Loss Drug May Cause Increased Risk of Rare Blindness, Study Claims
People with diabetes face a heightened risk of developing the rare disease. Researchers at the Harvard School of Public ...
News Medical on MSN1d
Study suggests gastric bypass can reduce cardiovascular disease risk, irrespective of weight loss
In a recent study published in JAMA Surgery, researchers investigated whether Roux-en-Y gastric bypass (RYGB) reduces ...
Medical Xpress on MSN2d
Popular prescription weight loss drugs linked to uncommon blindness condition
The drug encourages weight loss, and its use has snowballed since its launch as ... Mass Eye and Ear sees an unusually ...
Novo Nordisk shares shrug off concerns over study linking weight loss drugs to rare eye condition
Novo Nordisk investors appeared unperturbed Thursday by a critical Harvard report that linked weight loss drugs to a rare eye ...
Ozempic better than insulin in lowering the risk of certain cancers: study
Type 2 diabetes patients can significantly lower their risk for 10 obesity-related cancers if they take Ozempic instead of ...